Metabolic syndrome (MetS), considered a complex set of cardiovascular risk factorsrelated to abdominal fat and resistance to insulin, has been increasingprogressively and is strongly associated with high cardiovascularmorbimortality,1,2 with estimated prevalence around23.7%, according to Adult Treatment Panel III criteria.3 The main recommendations for MetS prevention andtreatment are the change in lifestyle through a multifactor approach based oneducation, regular physical exercise and a healthy diet, as well as pharmacologicalstrategies.1 Here, INS is linked to metabolic syndrome.